10.25384/SAGE.10315556.v1 Marika Cinausero Marika Cinausero Noemi Laprovitera Noemi Laprovitera Giovanna De Maglio Giovanna De Maglio Lorenzo Gerratana Lorenzo Gerratana Mattia Riefolo Mattia Riefolo Marianna Macerelli Marianna Macerelli Michelangelo Fiorentino Michelangelo Fiorentino Elisa Porcellini Elisa Porcellini Vanessa Buoro Vanessa Buoro Francesco Gelsomino Francesco Gelsomino Anna Squadrilli Anna Squadrilli Gianpiero Fasola Gianpiero Fasola Massimo Negrini Massimo Negrini Marcello Tiseo Marcello Tiseo Manuela Ferracin Manuela Ferracin Andrea Ardizzoni Andrea Ardizzoni Supplementary_Figure_1 – Supplemental material for KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC SAGE Journals 2019 anti-PD-1 immunotherapy nivolumab non-small cell lung cancer pembrolizumab 2019-11-16 13:06:42 Figure https://sage.figshare.com/articles/figure/Supplementary_Figure_1_Supplemental_material_for_KRAS_and_ERBB-family_genetic_alterations_affect_response_to_PD-1_inhibitors_in_metastatic_nonsquamous_NSCLC/10315556 <p>Supplemental material, Supplementary_Figure_1 for KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC by Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio, Lorenzo Gerratana, Mattia Riefolo, Marianna Macerelli, Michelangelo Fiorentino, Elisa Porcellini, Vanessa Buoro, Francesco Gelsomino, Anna Squadrilli, Gianpiero Fasola, Massimo Negrini, Marcello Tiseo, Manuela Ferracin and Andrea Ardizzoni in Therapeutic Advances in Medical Oncology</p>